openPR Logo
Press release

Research Report and Overview on Companion Diagnostics Market, 2016-2026

01-31-2018 11:02 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Research Report and Overview on Companion Diagnostics Market,

Companion diagnostics are tests to understand which patient can be benefited from a certain drug or what dosage should be prescribed based upon patient’s clinical diagnosis, which provides evidence required for the successful and harmless use of an equivalent drug or biological product to treat the medical condition. These are medical instruments that support doctors to elect which treatment and dosage should be given to patients personalized to their necessity.

Companion Diagnostics is utilized to ascertain who would benefit from treatment and it comes in handy to identify if someone cannot be cured, but also conversely can be harmed by use of specific drug used for their ailment. Technological advancements has brought a lot of changes in the method of disease treatment. Companion diagnostics is characterized by growing requirement for enhancedpersonalized patient treatment that gives healthcare providers and their patients an assurance about the treatment result in a positive way, contrary to traditional treatment procedure. Major impact of companion diagnostic will been on oncology therapy area.

Companion Diagnostics Market: Drivers and Restraints

Presently, companion diagnostics global market is driven by the technological advancement in healthcare industry, increase in various treatment procedures. Number of companion diagnostics can be given approval for a single drug as scientific knowledge advances with practical application of treatment. Although, cost related with latest technology acts as a key barrier for the growth of global companion diagnostics market.

Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1255

Companion Diagnostics Market: Segmentation

Companion diagnostic global market is segmented into following segments:

By Application

Colorectal Cancer

Breast Cancer

Lung Cancer

Melanoma

Urology

Gastric Cancer

By Technology

Immunohistochemistry

Molecular Diagnostics

In-situ Hybridization

FISH

CISH

Real Time PCR

Gene Sequencing

By Region

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia Pacific (China, India, ASEAN, Australia & New Zealand)

Japan

Middle East and Africa (GCC, S. Africa, N. Africa)

Visit For TOC@ https://www.futuremarketinsights.com/toc/rep-gb-1255

Companion Diagnostics Market: Overview

With rapid technological advancement, increase in the incidence of chronic disease, rise in aging population, increasing adoption rate of treatment of chronic disease, increase in number of prevalence of chronic disease around the globe are the factors expected to boost the companion diagnostics market over the forecast period.

Companion Diagnostics Market: Region-wise Outlook

Depending on geographic regions, global companion diagnostics market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan and Middle East & Africa.

North America is the leading market for companion diagnostics because of rapid technical inventions, huge investment on research and development in this region. Whereas, Asia-Pacificand Europeis projected to grow at a significant growth due to large consumer base, rising government initiatives for enhancing healthcare infrastructure, and high disposable income.

Companion Diagnostics Market: Key Players

Some of the key participating global players in companion diagnostics market global market are ARUP Laboratories, Roche Molecular Systems Inc., Dako Inc., Qiagen Ltd., bioMérieux Inc.,Ventana Medical Systems Inc., Abbott Molecular Inc., Myriad Genetics Inc.,Biogenex Laboratories, Inc., Thermo Fisher Scientific Inc., Leica Biosystems Nussloch GmbH and others.

ABOUT US:

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Research Report and Overview on Companion Diagnostics Market, 2016-2026 here

News-ID: 924101 • Views: 103

More Releases from Future Market Insights

How Changing Dynamics of Cable Testing Market are Reflecting on Growth Strategie …
Global Cable Testing Market: Introduction The cost of the substitution of cables that are concealed is very high. Faults in the cable, bending, kinking, and crushing, are not always visible, which has created the requirement for cable testing. Thus, cable testing helps check the cable functionality, cable quality, and cable conformity. Several times, cable testing by visual inspection is an effective way of identifying the actual problem before it causes any
How Transformative Trends in Self-Organising Network Market are Molding Strategi …
Self-Organising Network: Introduction With accelerated advancements and increasing complexities in the radio network technologies, such as those utilised for the development of LTE and 5G networks, which are used for planning, management, configuration, healing and optimisation, are required to be automated to facilitate efficiency. At present, suppliers are offering self-organising networks that possess the ability to offer optimum performance. Self-organising networks are use cases that perform network governance, including network planning,
Mining Vehicle AC Kits Market: Exploring the Impact of Trends on Strategies of K …
Mining Vehicle AC Kits Market: Introduction Cabin space in mining equipment has become more sophisticated in the recent past. The installation of mining vehicle AC kits has evolved from an optional feature to a necessary feature. Mining equipment manufacturers have made advancements in technology related to efficiency, performance and cost of air conditioning systems in order to make them affordable and economical to enable low-budget and compact installations without compromising on
Key Factors to Fuel Growth of the Talent Acquisition & Staffing Technology and S …
With the growing importance of recruiting and retaining top talent effectively and efficiently, smart hiring processes are the need of the hour. It is about time organisations move beyond merely scrutinising resumes. Salaries and benefits are important factors, but adopting ways that would make candidates an important part of the hiring process will attract the best talent. Studies reveal that due to discrepancies in existing Applicant Tracking Systems (ATS), hiring

All 5 Releases


More Releases for Companion

Companion Diagnostics Market – Growth , Opportunities and Applications
Companion diagnostics are tests to understand which patient can be benefited from a certain drug or what dosage should be prescribed based upon patient’s clinical diagnosis, which provides evidence required for the successful and harmless use of an equivalent drug or biological product to treat the medical condition. These are medical instruments that support doctors to elect which treatment and dosage should be given to patients personalized to their necessity. Companion
A Smart Companion to your TV
Following HELLO’s very successful Kickstarter campaign (1339% funded), Solaborate is launching the new and improved HELLO 2 on Kickstarter, along with HELLO Touch TV, HELLO Creator Edition and 2 Gadget Extensions. A Smart Companion to your TV HELLO 2, like its predecessor, turns any TV into a video communication and collaboration device. HELLO 2 does everything users love about the original even better with Alexa support, home automation (Zigbee), and Android games,
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test
Global Farm & Companion Animal Health Market
Veterinary healthcare products include pharmaceuticals, nutrition (feed additives) and devices for both companion and livestock animals. Companion animals include pets such as dogs, cats and horses; although in recent years the market has expanded reasonably for avian pets, reptiles and exotic fish. The healthcare products have transformed the health and quality of life for millions of pets across the world. The greatest challenge of maintaining pets is seeking the keenness
Global Companion Diagnostics Market to Grow Globally
Companion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and administered to the patient. Whole blood samples, tissues samples, or buccal samples are collected and tested for diagnosis and identification of targeted disease biomarker. CDx is usually utilized in identifying
Global Companion Diagnostics – Growth Companion for Personalized Medicine
Companion Diagnostics: Growth Companion for Personalized Medicine Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.